Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Cash shell Motif Bio posted a first-half loss and said it had closely reviewed more than 30 reverse takeover opportunities.
Net losses for the six months through June amounted to $0.99 million, compared to a profit of $4.81 million.
Motif Bio said discussions had progressed to the term sheet stage with several companies.
'The search is continuing for an appropriate reverse takeover candidate with the goal of completing a transaction before 28 January 2021, when the company's shares would be de-listed absent an reverse takeover candidate or other qualifying transaction,' the company said.